Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

A. Bazarbachi; A. Boumendil; H. Finel; M. Mohty; L. Castagna; D. Blaise; K.S. Peggs; B. Afanasyev; J.L. Diez-Martin; P. Corradini; D. Michonneau; S. Robinson; G. Gutiérrez García; F. Bonifazi; I. Yakoub-Agha; Z. Gülbas; A. Bloor; J. Delage; A. Esquirol; R. Malladi; C. Scheid; J. El-Cheikh; H. Ghesquières; S. Montoto; P. Dreger; A. Sureda

doi:10.1002/cncr.31755

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

A. Bazarbachi, A. Boumendil, H. Finel, M. Mohty, L. Castagna, D. Blaise, K.S. Peggs, B. Afanasyev, J.L. Diez-Martin, P. Corradini, D. Michonneau, S. Robinson, G. Gutiérrez García, F. Bonifazi, I. Yakoub-Agha, Z. Gülbas, A. Bloor, J. Delage, A. Esquirol, R. MalladiC. Scheid, J. El-Cheikh, H. Ghesquières, S. Montoto, P. Dreger, A. Sureda

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	90-98
Number of pages	9
Journal	Cancer
Volume	125
Issue number	1
DOIs	https://doi.org/10.1002/cncr.31755
Publication status	Published - 2019

Access to Document

10.1002/cncr.31755

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055479928&doi=10.1002%2fcncr.31755&partnerID=40&md5=0240d324c0f6cc56d9358ad645e20898

Cite this

Bazarbachi, A., Boumendil, A., Finel, H., Mohty, M., Castagna, L., Blaise, D., Peggs, K. S., Afanasyev, B., Diez-Martin, J. L., Corradini, P., Michonneau, D., Robinson, S., Gutiérrez García, G., Bonifazi, F., Yakoub-Agha, I., Gülbas, Z., Bloor, A., Delage, J., Esquirol, A., ... Sureda, A. (2019). Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. Cancer, 125(1), 90-98. https://doi.org/10.1002/cncr.31755

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. / Bazarbachi, A.; Boumendil, A.; Finel, H.; Mohty, M.; Castagna, L.; Blaise, D.; Peggs, K.S.; Afanasyev, B.; Diez-Martin, J.L.; Corradini, P.; Michonneau, D.; Robinson, S.; Gutiérrez García, G.; Bonifazi, F.; Yakoub-Agha, I.; Gülbas, Z.; Bloor, A.; Delage, J.; Esquirol, A.; Malladi, R.; Scheid, C.; El-Cheikh, J.; Ghesquières, H.; Montoto, S.; Dreger, P.; Sureda, A.

In: Cancer, Vol. 125, No. 1, 2019, p. 90-98.

Research output: Contribution to journal › Article › peer-review

Bazarbachi, A, Boumendil, A, Finel, H, Mohty, M, Castagna, L, Blaise, D, Peggs, KS, Afanasyev, B, Diez-Martin, JL, Corradini, P, Michonneau, D, Robinson, S, Gutiérrez García, G, Bonifazi, F, Yakoub-Agha, I, Gülbas, Z, Bloor, A, Delage, J, Esquirol, A, Malladi, R, Scheid, C, El-Cheikh, J, Ghesquières, H, Montoto, S, Dreger, P & Sureda, A 2019, 'Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party', Cancer, vol. 125, no. 1, pp. 90-98. https://doi.org/10.1002/cncr.31755

Bazarbachi, A. ; Boumendil, A. ; Finel, H. ; Mohty, M. ; Castagna, L. ; Blaise, D. ; Peggs, K.S. ; Afanasyev, B. ; Diez-Martin, J.L. ; Corradini, P. ; Michonneau, D. ; Robinson, S. ; Gutiérrez García, G. ; Bonifazi, F. ; Yakoub-Agha, I. ; Gülbas, Z. ; Bloor, A. ; Delage, J. ; Esquirol, A. ; Malladi, R. ; Scheid, C. ; El-Cheikh, J. ; Ghesquières, H. ; Montoto, S. ; Dreger, P. ; Sureda, A. / Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. In: Cancer. 2019 ; Vol. 125, No. 1. pp. 90-98.

@article{cb6f04729560454b8b9e7d4ea5b74ac6,

title = "Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party",

author = "A. Bazarbachi and A. Boumendil and H. Finel and M. Mohty and L. Castagna and D. Blaise and K.S. Peggs and B. Afanasyev and J.L. Diez-Martin and P. Corradini and D. Michonneau and S. Robinson and {Guti{\'e}rrez Garc{\'i}a}, G. and F. Bonifazi and I. Yakoub-Agha and Z. G{\"u}lbas and A. Bloor and J. Delage and A. Esquirol and R. Malladi and C. Scheid and J. El-Cheikh and H. Ghesqui{\`e}res and S. Montoto and P. Dreger and A. Sureda",

note = "Cited By :3 Export Date: 12 February 2020",

year = "2019",

doi = "10.1002/cncr.31755",

language = "English",

volume = "125",

pages = "90--98",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

AU - Bazarbachi, A.

AU - Boumendil, A.

AU - Finel, H.

AU - Mohty, M.

AU - Castagna, L.

AU - Blaise, D.

AU - Peggs, K.S.

AU - Afanasyev, B.

AU - Diez-Martin, J.L.

AU - Corradini, P.

AU - Michonneau, D.

AU - Robinson, S.

AU - Gutiérrez García, G.

AU - Bonifazi, F.

AU - Yakoub-Agha, I.

AU - Gülbas, Z.

AU - Bloor, A.

AU - Delage, J.

AU - Esquirol, A.

AU - Malladi, R.

AU - Scheid, C.

AU - El-Cheikh, J.

AU - Ghesquières, H.

AU - Montoto, S.

AU - Dreger, P.

AU - Sureda, A.

N1 - Cited By :3 Export Date: 12 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1002/cncr.31755

DO - 10.1002/cncr.31755

M3 - Article

VL - 125

SP - 90

EP - 98

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -